Condition: Pulmonary Arterial Hypertension · Connective Tissue Diseases · Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
The RECONNECTIVE Registry is an observational single center study, focused on the subgroup of precapillary pulmonary hypertension related to connective tissue diseases. All patients will have hemodynamic confirmation by right heart catheterization and will be follow-up for at least 5 years from admission. All patients diagnosed with Group I Pulmonary Arterial Hypertension (PAH) associated with Connective Tissue Diseases (CTD) and Group IV Pulmonary Hypertension (PH) with CTD will be included. The purpose of the registry is to learn and understand the clinical outcomes and natural history of the pulmonary arterial hypertension in this subgroup of patients to improve the medical care and treatment.
This description comes directly from the study's public registry record.
Jose Luis Hernandez Oropeza, PhD · +52 55 5487 0900 · elinternista@hotmail.com
Jose de Jesus Rodriguez Andoney, M.Sc. · +52 55 5487 0900 · andoneyjjr@hotmail.com
Always discuss trial participation with your own doctor first.
| Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán | Mexico City, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05665556